Cavitary Lung Lesions

Infectious Causes

• Tuberculosis and non-tuberculous mycobacteria (NTM) are predominant risk factors for cavitary disease, particularly for subsequent development of chronic pulmonary aspergillosis, according to the European Respiratory Society 1, 2
• NTM lung disease characteristically presents with nodular/bronchiectatic patterns and can progress to cavitation over months to years, as reported by the American Thoracic Society 2
• Aspergillus species cause cavitary lesions through multiple mechanisms, including aspergillomas forming within pre-existing cavities, chronic cavitary pulmonary aspergillosis (CCPA) creating new expanding cavities, and subacute invasive aspergillosis in immunocompromised patients, as described by the European Respiratory Society 3, 4, 5
• CCPA develops most commonly in pre-existing bronchopulmonary or pleural cavities from prior TB, NTM infection, COPD, or treated lung cancer, according to the European Respiratory Society 1
• The distinctive hallmarks of CCPA include new and/or expanding cavities of variable wall thickness with or without intracavitary fungal ball formation, often with pleural thickening and marked parenchymal destruction, as reported by the European Respiratory Society 3, 1
• Aspergillomas present as upper-lobe, solid, round or oval intracavitary masses with the characteristic "air-crescent" sign, mobile on prone positioning, according to the European Respiratory Society 1
• Pseudomonas aeruginosa causes cavitation in 4-15% of severe pneumonia cases and requires specific antimicrobial coverage, as recommended by the Infectious Diseases Society of America 6
• Lung abscesses from septic emboli often involve mixed anaerobic flora, requiring cultures specifically for anaerobes, as reported by the Infectious Diseases Society of America 6

Malignant Causes

• Malignancy is a leading cause of cavitary lesions in adults, particularly in patients with thick cavity walls, older age, smoking history, and hemoptysis, according to the American College of Chest Physicians 7, 8, 9
• Necrotic lung carcinoma can mimic aspergilloma radiographically, as reported by the European Respiratory Society 3
• Multiple lesions of varying size are most likely malignant, particularly in patients with known primary tumors, according to the American Thoracic Society 7
• Metastases should be considered in the differential, especially with multiple cavitary nodules, as recommended by the European Respiratory Society 5, 8

Autoimmune and Inflammatory Causes

• Granulomatosis with polyangiitis (Wegener's granulomatosis) causes cavitary nodules as part of systemic vasculitis, according to the American College of Rheumatology 7, 8, 9
• Rheumatoid nodules can cavitate and may be pure rheumatoid nodules or contain Aspergillus superinfection, as reported by the European Respiratory Society 4, 5, 8
• Other granulomatous diseases, including sarcoidosis (particularly fibrocystic sarcoidosis), predispose to cavity formation, according to the European Respiratory Society 3, 1

Pre-existing Structural Lung Disease

• COPD, prior pneumothorax, bronchiectasis, and ankylosing spondylitis create structural abnormalities that predispose to secondary infection and cavitation, as reported by the European Respiratory Society 3, 1
• Pneumoconiosis and progressive massive fibrosis in silicosis provide substrate for cavity development, according to the European Respiratory Society 3, 1

Critical Diagnostic Considerations

• Thick-walled cavities with irregular margins suggest malignancy, while thin-walled cavities with air-fluid levels suggest infection, as recommended by the American College of Radiology 9
• Upper lobe predominance suggests tuberculosis, NTM, or aspergillosis, according to the European Respiratory Society 1
• Multiple cavities with surrounding consolidation suggest bacterial infection or septic emboli, as reported by the Infectious Diseases Society of America 9, 6
• Chronic cavitary lesions present for >3 months require evaluation for chronic pulmonary aspergillosis, especially with positive Aspergillus serology, as recommended by the Infectious Diseases Society of America 9

Cavitary Lung Lesions Diagnosis and Management

Infectious Causes

• The European Respiratory Society recommends considering chronic cavitary pulmonary aspergillosis (CCPA) in patients with chronic symptoms and upper-lobe cavities, with a positive Aspergillus IgG or precipitins test (>90% of cases) 10, 11
• Chronic cavitary lesions present for >3 months require evaluation for chronic pulmonary aspergillosis, especially with positive Aspergillus IgG or precipitins testing 10, 11
• Necrotic lung carcinoma can mimic aspergilloma radiographically and requires tissue diagnosis for definitive differentiation, according to the European Respiratory Journal 10

Diagnostic Approach

• Surgical biopsy is considered when less invasive methods are non-diagnostic, particularly for progressive cavitary lesions despite empiric therapy, as recommended by the Clinical Microbiology and Infection journal 12
• Surgical resection or biopsy is also considered for hemoptysis from a single cavitary lesion, always performing CT first to search for other lesions, as suggested by the Clinical Microbiology and Infection journal 12
• Infiltration into pericardium, great vessels, bone, or thoracic soft tissue requires surgical intervention, according to the Clinical Microbiology and Infection journal 12

Cavitary Lung Lesions Etiology

Infection-Related Causes

• Koksidioidomikozis pnömonisinde enfekte dokunun tamamen ayrılması sonucu ince duvarlı kavite kalıntı olarak kalır, vakaların %5'inde görülür 13
• Nodüler veya kaviter lezyonlar invaziv filamentöz fungal enfeksiyonu düşündürür; ancak ayırıcı tanıda mikobakteriler, Nocardia, Pneumocystis veya Pseudomonas aeruginosa gibi diğer mikroorganizmalar da yer alır 14

Diagnostic Considerations

• Nötropenik hastalarda ilk 48 saat sonrası konvansiyonel akciğer grafileri anormallikleri sadece %10 gösterirken, yüksek çözünürlüklü BT taramalarında %50 hastada patolojik bulgular ortaya çıkar 14
• İnvaziv pulmoner aspergillozlu hastalarda etkili antifungal tedaviye rağmen ilk hafta pulmoner infiltratların hacmi artabilir; bu bulgu tek başına tedavinin refrakter olduğunu göstermez 14

Evaluation and Management of Cavitary Lung Lesions

Infectious Etiology – Aspergillosis

• Chronic pulmonary aspergillosis manifests in three patterns: (1) aspergilloma forming within pre‑existing cavities, identified by the “air‑crescent” sign and positional mobility; (2) chronic cavitary pulmonary aspergillosis (CCPA) producing new, progressively enlarging cavities over ≥ 3 months; and (3) sub‑acute invasive aspergillosis occurring in immunocompromised individuals. 15

• In patients with rheumatoid disease, pulmonary rheumatoid nodules may undergo cavitation and can be colonised by Aspergillus, resulting in mixed fungal‑rheumatoid lesions. 16

Malignant Etiology

• In adult patients, thick cavity walls (> 4 mm), irregular margins, older age, a history of smoking, and hemoptysis markedly increase the likelihood that a cavitary lung lesion is malignant. 17

• When multiple cavitary lesions of varying sizes are identified—especially in individuals with a known primary malignancy—the probability of a malignant process is high. 18

Diagnostic Imaging

• Computed tomography (CT) of the chest is recommended to assess cavity wall thickness, margin characteristics, anatomical distribution, and associated parenchymal findings in all patients with suspected cavitary lesions. 17

Microbiological Evaluation

• For patients with chronic cavitary lesions, sputum and blood cultures should be obtained to detect mycobacterial, fungal, and bacterial pathogens. 18

Indications for Percutaneous Transthoracic Lung Biopsy (PTLB)

• PTLB is advised when (a) bronchoscopy fails to obtain a diagnosis or the lesion is not bronchoscopically accessible on CT; (b) multiple nodules are present in a patient without a known malignancy or with prolonged remission; (c) persistent infiltrates remain unexplained after sputum/blood cultures, serologic testing, and bronchoscopy; and (d) clinical risk factors (e.g., age, smoking) indicate a high probability of malignancy. 17

Tissue Sampling Techniques

• Needle aspiration of cavitating lesions should be performed to acquire material for bacteriologic analysis, aiding differentiation between neoplastic and infectious etiologies when clinical presentation is ambiguous. 18

• Cutting‑needle biopsy (CNB) provides histologic specimens that enable definitive diagnosis of benign lesions and can reduce the need for diagnostic surgical procedures by up to 50 %. 17